The Hidden 5–15%: Unlocking Recoverable Capacity in Drug Substance, Drug Product & Packaging

On-Demand

Pharma manufacturing consistently underperforms other chemicals sectors on asset utilisation, even though most networks have 5–15% recoverable capacity sitting in existing DS, DP, and packaging lines, no new assets required. The issue isn’t data volume, but the lack of standardised, scalable operational intelligence that can travel across products, lines, and sites.

In this session, we’ll show how pharma manufacturers, CDMOs, and generics producers can turn existing data into a GMP-ready operational control and efficiency layer. We’ll walk through a practical framework that unifies process and operations into a single contextualised view from DS through DP to packaging, standardises performance and loss analytics across sites, and uses exception-based monitoring with AI-assisted decision support to surface issues before they impact batches or schedules. We’ll close with a live Seeq demo of Operations, Tech Ops, and Digital Manufacturing teams unlocking hidden capacity, improving throughput and right-first-time, and deferring unnecessary capex.

Speakers

Paolo Braiuca

Industry Principal, Pharma

Tatum O'Kennedy

Senior Solution Consultant

Asif Hassan

Senior Analytics Engineer